Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aronow

Showing results (341-350 of 1,356) with videos related to

Pageof 136
Sort By:
The American Journal of Cardiology|May 15, 1997
Association between plasma homocysteine and extracranial carotid arterial disease in older personsW S Aronow, C Ahn, M R Schoenfeld
Current Hypertension Reports|October 20, 2017
Managing Hypertension in Patients Aged 75 Years and OlderYogita Rochlani, Mohammed Hasan Khan, Wilbert S Aronow
Cardiology in Review|June 10, 2026
Childhood Obesity: Epidemiology, Risk Factors, Prevention, and Emerging Treatment StrategiesSomar Hadid, William H Frishman, Wilbert S Aronow
Cardiology in Review|April 7, 2026
Caffeine and Cardiovascular Outcomes: Current Evidence and Clinical PerspectivesNegarsadat Neshat, William H Frishman, Wilbert S Aronow
Clinical Pharmacology and Therapeutics|April 1, 1980
Effects of acebutolol and propranolol on left ventricular performance assessed by echocardiographyP A Chandraratna, W S Aronow, A Laddu
Cardiology in Review|January 16, 2026
Lymphedema: A Narrative Review of Recent LiteratureElisheva Eisenberg, William H Frishman, Wilbert S Aronow
Archives of Medical Sciences. Atherosclerotic Diseases|July 7, 2025
Omecamtiv mecarbil, a cardiac myosin activator with potential efficacy in heart failureMohammed Kallash, William H Frishman, Wilbert S Aronow
Cardiology in Review|September 19, 2025
Polycystic Ovary Syndrome and Cardiovascular Disease: Pathophysiology, Clinical Evidence, and Preventive StrategiesRimsha Ahmad, William H Frishman, Wilbert S Aronow
Cardiology in Review|September 10, 2024
Cardiac Complications of Multiple Myeloma TreatmentsAatif Khurshid, William H Frishman, Wilbert S Aronow
Cardiology in Review|December 15, 2025
Therapeutic Value of SGLT2 Inhibitors in the Management of Congestive Heart FailureOmar Seyam, William H Frishman, Wilbert S Aronow
Pageof 136

Showing results (341-350 of 1,356) with videos related to

Sort By:
Pageof 136
The American Journal of Cardiology|May 15, 1997
Association between plasma homocysteine and extracranial carotid arterial disease in older personsW S Aronow, C Ahn, M R Schoenfeld
Current Hypertension Reports|October 20, 2017
Managing Hypertension in Patients Aged 75 Years and OlderYogita Rochlani, Mohammed Hasan Khan, Wilbert S Aronow
Cardiology in Review|June 10, 2026
Childhood Obesity: Epidemiology, Risk Factors, Prevention, and Emerging Treatment StrategiesSomar Hadid, William H Frishman, Wilbert S Aronow
Cardiology in Review|April 7, 2026
Caffeine and Cardiovascular Outcomes: Current Evidence and Clinical PerspectivesNegarsadat Neshat, William H Frishman, Wilbert S Aronow
Clinical Pharmacology and Therapeutics|April 1, 1980
Effects of acebutolol and propranolol on left ventricular performance assessed by echocardiographyP A Chandraratna, W S Aronow, A Laddu
Cardiology in Review|January 16, 2026
Lymphedema: A Narrative Review of Recent LiteratureElisheva Eisenberg, William H Frishman, Wilbert S Aronow
Archives of Medical Sciences. Atherosclerotic Diseases|July 7, 2025
Omecamtiv mecarbil, a cardiac myosin activator with potential efficacy in heart failureMohammed Kallash, William H Frishman, Wilbert S Aronow
Cardiology in Review|September 19, 2025
Polycystic Ovary Syndrome and Cardiovascular Disease: Pathophysiology, Clinical Evidence, and Preventive StrategiesRimsha Ahmad, William H Frishman, Wilbert S Aronow
Cardiology in Review|September 10, 2024
Cardiac Complications of Multiple Myeloma TreatmentsAatif Khurshid, William H Frishman, Wilbert S Aronow
Cardiology in Review|December 15, 2025
Therapeutic Value of SGLT2 Inhibitors in the Management of Congestive Heart FailureOmar Seyam, William H Frishman, Wilbert S Aronow
Pageof 136